Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

256 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Assessment of prognostic factors in alcoholic liver disease: toward a global quantitative expression of severity.
Orrego H, Israel Y, Blake JE, Medline A. Orrego H, et al. Among authors: israel y. Hepatology. 1983 Nov-Dec;3(6):896-905. doi: 10.1002/hep.1840030602. Hepatology. 1983. PMID: 6629318
Interrelation of the hypermetabolic state, necrosis, anemia and cell enlargement as determinants of severity in alcoholic liver disease.
Orrego H, Blake JE, Medline A, Israel Y. Orrego H, et al. Among authors: israel y. Acta Med Scand Suppl. 1985;703:81-95. doi: 10.1111/j.0954-6820.1985.tb08906.x. Acta Med Scand Suppl. 1985. PMID: 3867246 No abstract available.
Sinusoidal caliber in alcoholic and nonalcoholic liver disease: diagnostic and pathogenic implications.
Vidins EI, Britton RS, Medline A, Blendis LM, Israel Y, Orrego H. Vidins EI, et al. Among authors: israel y. Hepatology. 1985 May-Jun;5(3):408-14. doi: 10.1002/hep.1840050311. Hepatology. 1985. PMID: 3997070
Long-term treatment of alcoholic liver disease with propylthiouracil.
Orrego H, Blake JE, Blendis LM, Compton KV, Israel Y. Orrego H, et al. Among authors: israel y. N Engl J Med. 1987 Dec 3;317(23):1421-7. doi: 10.1056/NEJM198712033172301. N Engl J Med. 1987. PMID: 3317042 Clinical Trial.
Long-term treatment of alcoholic liver disease with propylthiouracil.
Orrego H, Blake JE, Blendis LM, Compton KV, Israel Y. Orrego H, et al. Among authors: israel y. Lancet. 1988 Apr 16;1(8590):892. doi: 10.1016/s0140-6736(88)91649-2. Lancet. 1988. PMID: 2895407 Clinical Trial. No abstract available.
Thyroid hormones in alcoholic liver disease. Effect of treatment with 6-n-propylthiouracil.
Israel Y, Walfish PG, Orrego H, Blake J, Kalant H. Israel Y, et al. Gastroenterology. 1979 Jan;76(1):116-22. Gastroenterology. 1979. PMID: 758132 Clinical Trial.
Serum triiodothyronine and other clinical and laboratory indices of alcoholic liver disease.
Walfish PG, Orrego H, Israel Y, Blake J, Kalant H. Walfish PG, et al. Among authors: israel y. Ann Intern Med. 1979 Jul;91(1):13-6. doi: 10.7326/0003-4819-91-1-13. Ann Intern Med. 1979. PMID: 464436
Effect of short-term therapy with propylthiouracil in patients with alcoholic liver disease.
Orrego H, Kalant H, Israel Y, Blake J, Medline A, Rankin JG, Armstrong A, Kapur B. Orrego H, et al. Among authors: israel y. Gastroenterology. 1979 Jan;76(1):105-15. Gastroenterology. 1979. PMID: 758131 Clinical Trial.
Long-term treatment of alcoholic liver disease with propylthiouracil. Part 2: Influence of drop-out rates and of continued alcohol consumption in a clinical trial.
Orrego H, Blake JE, Blendis LM, Compton KV, Volpe R, Israel Y. Orrego H, et al. Among authors: israel y. J Hepatol. 1994 Mar;20(3):343-9. doi: 10.1016/s0168-8278(94)80005-7. J Hepatol. 1994. PMID: 8014444 Clinical Trial.
Hepatocyte enlargement and portal hypertension.
Orrego H, Blendis LM, Israel Y. Orrego H, et al. Among authors: israel y. Hepatology. 1990 Dec;12(6):1454. doi: 10.1002/hep.1840120638. Hepatology. 1990. PMID: 2258165 No abstract available.
256 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback